FDA-Inspected Site

INTERVEIN RESEARCH LABS PRIVATE LIMITED

3 FDA inspections are on record for INTERVEIN RESEARCH LABS PRIVATE LIMITED in Ahmedabad, India.

483· Form 483 issued

Ahmedabad, India · Last updated August 15, 2026

Overview

  • 3 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-05-16.

At a glance

Inspections

3

Form 483s

3

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
14 May 2025 – 16 May 2025Human Drugs483View 483 →
20 Jun 2024 – 25 Jun 2024Human Drugs483View 483 →
10 Nov 2022 – 14 Nov 2022Human Drugs483On file

Observations on record

Form 483 observations cited at this site, most recent first.

16 May 2025
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Marcellinus D Dordunoo

16 May 2025
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Marcellinus D Dordunoo

16 May 2025
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Marcellinus D Dordunoo

25 Jun 2024
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Bijoy Panicker

25 Jun 2024
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Bijoy Panicker

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.68(a)Cited across public-safe Form 483 observations2x
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind INTERVEIN RESEARCH LABS PRIVATE LIMITED's 3 Form 483s

Recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat